ArticleJournal of gastrointestinal oncology2022

Low CPEB1 levels may predict the benefit of 5-fluorouracil treatment in patients with colon or stomach adenocarcinoma.

Jing-Zhu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.